SOPHiA GENETICS (SOPH) Invested Capital (2020 - 2026)

SOPHiA GENETICS has disclosed Invested Capital across 6 years of filings, most recently posting $131.1 million for Q2 2026.

• In Q2 2026, Invested Capital rose 5.6% year-over-year to $131.1 million; the TTM figure through Jun 2026 stood at $131.1 million (up 5.6% YoY), while the FY2025 annual figure was $94.9 million, down 13.53% from the prior year.
• Invested Capital came in at $131.1 million for Q2 2026 at SOPHiA GENETICS, up from $93.5 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $151.4 million in Q4 2023 to a low of $93.5 million in Q1 2026.
• Average Invested Capital over 4 years is $117.4 million, with a median of $116.9 million recorded in 2024.
• Year-over-year, Invested Capital declined 27.55% in 2024 and increased 5.6% in 2026.
• Over 4 years, Invested Capital stood at $151.4 million in 2023, then decreased by 27.55% to $109.7 million in 2024, then dropped by 13.53% to $94.9 million in 2025, then surged by 38.2% to $131.1 million in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $131.1 million in Q2 2026, $93.5 million in Q1 2026, and $94.9 million in Q4 2025.